Veterinary Medicines

Bravoxin 10 suspensija injekcijām liellopiem un aitām

Authorised
  • Clostridium novyi, type D, toxoid
  • Clostridium sordellii, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium perfringens, type A, alpha toxoid
Download as PDF

Product identification

Medicine name:
Bravoxin 10 suspensija injekcijām liellopiem un aitām
Active substance:
  • Clostridium novyi, type D, toxoid
  • Clostridium sordellii, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium novyi, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium perfringens, type A, alpha toxoid
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium novyi, type D, toxoid
    17.40
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    4.40
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Tetanus toxoid adsorbed
    4.90
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    4.60
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.80
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.30
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B and C, beta toxoid
    18.20
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type A, alpha toxoid
    0.50
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • PVD
Authorisation number:
  • V/I/21/0070
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Elvetis
Destination wholesaler:
  • Magnum Veterinarija SIA
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."